Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºñ¼Ò¼¼Æ÷ Æó¾ÏÁ¾ÀÇ »óÇǼºÀåÀÎÀÚ ¼ö¿ëü »óÅÂ¿Í ÀÓ»ó-º´¸®ÇÐÀû ¿¬°ü¼º: ´Ü¹é ¹ßÇö, À¯ÀüÀÚ ÁõÆø ¹× »ýÁ¸ºÐ¼® Clinicopathologic Analysis of Epidermal Growth Factor Receptor Status in Non-small Cell Lung Cancer: Protein Expression, Gene Amplification and Survival Analysis

´ëÇѺ´¸®ÇÐȸÁö 2007³â 41±Ç 6È£ p.387 ~ 392
À̽±¸, ÃÖÁø, Àå¼¼Áø,
¼Ò¼Ó »ó¼¼Á¤º¸
À̽±¸ ( Lee Sung-Koo ) 
°­¿ø´ëÇб³ º´¸®°ú

ÃÖÁø ( Choi Jene ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø º´¸®°ú
Àå¼¼Áø ( Jang Se-Jin ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background : Abnormal over-expression or gene amplification of epidermal growth factor receptor (EGFR) is important in the prognosis of non-small cell lung cancer (NSCLC). We investigated the frequency of EGFR protein expression and gene amplification, and the correlation between EGFR status and survival in NSCLC.

Methods : We examined 360 cases of microarrayed NSCLC tissues for the EGFR protein expression and EGFR gene amplification using immunohistochemistry and fluorescent in situ hybridization.

Results : EGFR protein expression and EGFR gene amplification occurred in 110 cases (30.6%) and 24 cases
(6.7%), respectively. EGFR prote in expression and gene amplification were more frequent in squamous cell carcinoma than in adenocarcinoma. Differences in EGFR protein expression did not dramatically affect survival curves (p=0.740), but differences in gene amplification did (p<0.05): EGFR gene amplification was associated with a lower 5-year survival rate.
Conclusion : EGFR protein expression and gene amplification showed moderate correlation with each other. EGFR gene amplification predicted a poor prognosis, whereas EGFR protein expression did not.

Å°¿öµå

Carcinoma;Non-small-cell lung;Receptor;Epidermal growth factor;In situ hybridization

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS